Year: 2013
Type: article
Abstract: Meeting abstracts A previous clinical trial carried out by our group in which high numbers of haploidentical donor lymphoid cells containing CD3+ cells (1 - 2 x 108 CD3+ cells/kg) were infused into recipients with refractory hematological malignancy found that 14/27 patients gave a response, 9 or
Authors: Loren Fast, John Reagan, Peter Quesenberry
Institution: Rhode Island Hospital
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,490
OpenAlex ID: W2009132817